Charité is Europe's largest university hospital, with a Comprehensive Cancer Center and the Berlin Institute of Health.
Charité, Universitätsmedizin Berlin, is Europe's largest university hospital and hosts the Charité Comprehensive Cancer Center and the Berlin Institute of Health; it ranks twelfth in the Newsweek/Statista oncology list. Its cancer strengths lie in haematology, cell therapy and translational research carried out with the Max Delbrück Center for Molecular Medicine, with Ulrich Keilholz, Christof von Kalle, Lars Bullinger and the paediatric oncologist Angelika Eggert among its leaders. OnCo links it to the Atlas pathology foundation model developed with Aignostics and Mayo Clinic, to Deutsche Krebshilfe and SIOP Europe, and to the idea of hospital-exemption cell therapies made at scale with a shared registry. Whether academic cell therapy manufacturing can match industry on quality and cost is the open question. Its cell therapy programme is the place to start.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Charité - Universitätsmedizin Berlin, including child institutions. 1,567 works · 18,047 citations · 76% open access · 12% clinical trials · 2% reviews.
Angelika Eggert is a paediatric oncologist and neuroblastoma researcher.
Gene therapy pioneer who developed methods to track vector integration in treated patients.
Lars Bullinger is a haematologist and AML genomics researcher leading Charité's haematology department.
Berlin oncologist who led SEMPET, the study showing that a PET scan can tell which residual masses after chemotherapy for seminoma still contain cancer, sparing many men further treatment.
Berlin oncologist who led GATSBY, the trial showing that the antibody-drug conjugate T-DM1 did not beat taxane chemotherapy in previously treated HER2-positive stomach cancer.
Ulrich Keilholz is a medical oncologist who directs the Charité Comprehensive Cancer Center.
Shares Deutsche Krebsgesellschaft, German Cancer Consortium (DKTK), Deutsches Netzwerk für Personalisierte Medizin, Proton therapy machines: cyclotrons, synchrotrons and single-room systems.
Shares Deutsche Krebsgesellschaft, Deutsche Krebshilfe, Max Delbrück Center for Molecular Medicine, German Cancer Consortium (DKTK).
Shares CyberKnife robotic radiosurgery, Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy.
Shares Deutsche Krebsgesellschaft, Deutsche Krebshilfe, Deutsches Netzwerk für Personalisierte Medizin, Proton therapy machines: cyclotrons, synchrotrons and single-room systems.
Shares Aignostics, Atlas (Aignostics, Mayo Clinic, Charité), Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Proton therapy machines: cyclotrons, synchrotrons and single-room systems.
Shares Deutsche Krebsgesellschaft, German Cancer Consortium (DKTK), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy.
Shares CyberKnife robotic radiosurgery, Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy.
Shares Deutsche Krebshilfe, Deutsches Netzwerk für Personalisierte Medizin, nationales Netzwerk Genomische Medizin Lungenkrebs.